Overview
Location
United States, North Carolina, Raleigh
Employees
201-500
Founded date
1994
Mentions in press and media 11
| Date | Title | Description |
| Sign up to see | Sign up to see | Sign up to see |
| Jan 27, 2012 | North Carolina diagnostics firm LipoScience names new COO | Fischer brings to his new post more than 25 years of experience, particularly in in vitro diagnostics. Before joining LipoScience, Fischer was vice president of development for the women’s health and cancer business at Becton Dickinson (NYS... |
| Jan 5, 2012 | Heart disease diagnostic system from LipoScience seeks FDA 510(k) clearance | LipoScience’s 510(k) submission to the FDA aims to broaden the NMR test’s reach. If the FDA grants regulatory clearance for a new analyzer that LipoScience calls Vantera, laboratories in hospitals and research facilities across the country ... |
| Jun 24, 2011 | N.C. diagnostics firm LipoScience files for $86M IPO | LipoScience plans to use proceeds from its stock offering to expand its sales and marketing and fund continued R&D for new tests to supplement an already commercialized blood test to gauge the risk of cardiovascular disease. LipoScience... |
| Mar 18, 2010 | Cardiac biomarker gets second life | By Mary Vanac Jake Orville always thought the cardiac inflammation biomarker developed by Dr. Stanley Hazen and his colleagues at the Cleveland Clinic was a valuable and proven technology. But his efforts to make it a commercial success for... |
| Mar 17, 2010 | Cleveland HeartLab: How to go to market with diagnostic test? | Based on Hazen’s research, Cleveland Clinic spin-off company PrognostiX had commercialized a test for myeloperoxidase–an enzyme that indicates inflammation in the artery walls of the heart, which can predict fatal heart attacks or strokes. ... |
| Cleveland HeartLab: How to go to market with diagnostic test? | Updated 4:29 p.m., March 18, 2010 The cardiac inflammation biomarker developed by Dr. Stanley Hazen and his colleagues at the Cleveland Clinic was a valuable and proven technology, thought Jake Orville, president and chief executive of Clev... | |
| North Carolina diagnostics firm LipoScience names new COO | Diagnostics company LipoScience, which is in the midst of plans for an initial public stock offering, now has a new chief operating officer. Timothy Fischer joined LipoScience in 2010 as the company’s vice president of research and developm... | |
| N.C. diagnostics firm LipoScience files for $86M IPO | Diagnostics company LipoScience aims to become North Carolina’s next public company. Raleigh, North Carolina-based LipoScience has filed with securities regulators plans to raise up to $86.2 million in an initial public stock offering. It’s... | |
| Heart disease diagnostic system from LipoScience seeks FDA 510(k) clearance | Diagnostics firm LipoScience is seeking U.S. Food and Drug Administration clearance for a new lab-based technology platform that tests for heart disease risks. LipoScience has commercialized a blood test that measures the density of lipopro... |
Show more
Reviews 0
FAQ about LipoScience
When was LipoScience founded?
LipoScience was founded in 1994.
What has the press written about LipoScience?
Parsers VC has collected 11 articles mentioning LipoScience, among them “North Carolina diagnostics firm LipoScience names new COO” (Jan 27, 2012) and “Heart disease diagnostic system from LipoScience seeks FDA 510(k) clearance” (Jan 5, 2012).
Is LipoScience still active?
LipoScience is probably closed: its latest activity on Parsers VC dates from Apr 19, 2012.